Reduced serum miR‐202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein

Abstract The current study investigated whether the expression of miR‐202 was abnormal in the serum of patients with Alzheimer's disease (AD) and evaluated the potential clinical significance, thereby shedding light on the diagnosis of AD. Here, our data showed that the level of miR‐202 decreas...

Full description

Bibliographic Details
Main Authors: Li‐Hua Dong, Lei Sun, Wen‐Jing Zhang, Xiao‐Yan Wang, Jia‐Mei Li
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12391

Similar Items